Radiation dose-volume effects in the esophagus
- PMID: 20171523
- PMCID: PMC3587781
- DOI: 10.1016/j.ijrobp.2009.05.070
Radiation dose-volume effects in the esophagus
Abstract
Publications relating esophageal radiation toxicity to clinical variables and to quantitative dose and dose-volume measures derived from three-dimensional conformal radiotherapy for non-small-cell lung cancer are reviewed. A variety of clinical and dosimetric parameters have been associated with acute and late toxicity. Suggestions for future studies are presented.
Copyright 2010 Elsevier Inc. All rights reserved.
Conflict of interest statement
Conflict of interest: none.
Figures


Similar articles
-
Combination of longitudinal and circumferential three-dimensional esophageal dose distribution predicts acute esophagitis in hypofractionated reirradiation of patients with non-small-cell lung cancer treated in stereotactic body frame.Int J Radiat Oncol Biol Phys. 2005 Jul 1;62(3):652-8. doi: 10.1016/j.ijrobp.2004.10.030. Int J Radiat Oncol Biol Phys. 2005. PMID: 15936541
-
Predictors of radiation-induced esophageal toxicity in patients with non-small-cell lung cancer treated with three-dimensional conformal radiotherapy.Int J Radiat Oncol Biol Phys. 2003 Feb 1;55(2):337-41. doi: 10.1016/s0360-3016(02)03937-8. Int J Radiat Oncol Biol Phys. 2003. PMID: 12527046
-
Clinical and dosimetric predictors of radiation-induced esophageal toxicity.Int J Radiat Oncol Biol Phys. 1999 Aug 1;45(1):97-103. doi: 10.1016/s0360-3016(99)00163-7. Int J Radiat Oncol Biol Phys. 1999. PMID: 10477012
-
Dosimetric and clinical predictors for radiation-induced esophageal injury.Int J Radiat Oncol Biol Phys. 2005 Feb 1;61(2):335-47. doi: 10.1016/j.ijrobp.2004.06.014. Int J Radiat Oncol Biol Phys. 2005. PMID: 15667951 Review.
-
Esophagitis, treatment-related toxicity in non-small cell lung cancer.Rev Recent Clin Trials. 2012 Feb;7(1):31-5. doi: 10.2174/157488712799363235. Rev Recent Clin Trials. 2012. PMID: 21864251 Free PMC article. Review.
Cited by
-
Systematic Review of Normal Tissue Complication Models Relevant to Standard Fractionation Radiation Therapy of the Head and Neck Region Published After the QUANTEC Reports.Int J Radiat Oncol Biol Phys. 2018 Feb 1;100(2):391-407. doi: 10.1016/j.ijrobp.2017.09.041. Epub 2017 Sep 29. Int J Radiat Oncol Biol Phys. 2018. PMID: 29353656 Free PMC article.
-
Phase II study of accelerated high-dose radiotherapy with concurrent chemotherapy for patients with limited small-cell lung cancer: Radiation Therapy Oncology Group protocol 0239.Int J Radiat Oncol Biol Phys. 2012 Jul 15;83(4):e531-6. doi: 10.1016/j.ijrobp.2012.01.075. Epub 2012 May 5. Int J Radiat Oncol Biol Phys. 2012. PMID: 22560543 Free PMC article. Clinical Trial.
-
Advances in Radiobiology of Stereotactic Ablative Radiotherapy.Front Oncol. 2020 Aug 7;10:1165. doi: 10.3389/fonc.2020.01165. eCollection 2020. Front Oncol. 2020. PMID: 32850333 Free PMC article. Review.
-
Radiation-induced oesophagitis in lung cancer patients. Is susceptibility for neutropenia a risk factor?Strahlenther Onkol. 2012 Jul;188(7):564-7. doi: 10.1007/s00066-012-0098-z. Epub 2012 Apr 29. Strahlenther Onkol. 2012. PMID: 22543884 Clinical Trial.
-
Amifostine- and chemoradiotherapy-related esophagitis in small cell lung cancer: a single institutional series and literature update.Lung Cancer (Auckl). 2018 Sep 10;9:79-84. doi: 10.2147/LCTT.S155315. eCollection 2018. Lung Cancer (Auckl). 2018. PMID: 30237747 Free PMC article.
References
-
- Curran W, Jr, Scott C, Langer C, et al. Phase III comparison of sequential vs. concurrent chemoradiation for patients with unresected stage III non-small cell lung cancer: Initial report of RTOG 9410. Proc ASCO. 2000;19:484a.
-
- Furuse K, Fukuoka M, Kawahara M, et al. Phase III study of concurrent vs. sequential thoracic radiotherapy in combination with mitomycin, vindesine, and cisplatin in unresectable stage III non-small cell lung cancer. J Clin Oncol. 1999;17:2692–2699. - PubMed
-
- Cox JD, Pajak TF, Asbell S, et al. Interruptions of high-dose radiation therapy decrease long-term survival of favorable patients with unresectable non-small cell carcinoma of the lung: Analysis of 1244 cases from 3 RTOG trials. Int J Radiat Oncol Biol Phys. 1993;27:493–498. - PubMed
-
- Timmerman R, McGarry R, Yiannoutsos C, et al. Excessive toxicity when treating central tumors in a phase II study of stereotactic body radiation therapy for medically inoperable early-stage lung cancers. J Clin Oncol. 2006;24:4833–4839. - PubMed
-
- Onishi H, Shirato H, Nagata Y, et al. Hypofractionated stereotactic radiotherapy (HypoFXSRT) for stage I non-small cell lung cancer: Updated results of 257 patients in a Japanese multi-institutional study. J Thoracic Oncol. 2007;2(7 Suppl 3):S94–S100. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical